当前位置:
X-MOL 学术
›
J. Hepatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Reply to: “Pyroptosis in liver failure: A twisted firestarter”
Journal of Hepatology ( IF 26.8 ) Pub Date : 2024-10-21 , DOI: 10.1016/j.jhep.2024.10.021 Vlad Taru, Thomas Reiberger
中文翻译:
回复: “肝衰竭中的细胞焦亡:扭曲的纵火者”
VT 和 TR 都起草并审查了知识内容的回复信。
VT由基督教-多普勒研究协会和勃林格殷格翰RCV GmbH & Co KG(CD10271603)资助;罗马尼亚研究、创新和数字化部(PNRR/2022/C9/MCID/I8).TR获得了Abbvie、Boehringer Ingelheim、Gilead、Intercept/Advanz Pharma、MSD、Myr Pharmaceuticals、Philips Healthcare、Pliant、Siemens和W. L. Gore & Associates的资助;来自Abbvie, Echosens, Gilead, Intercept/Advanz Pharma, Roche, MSD, W. L. Gore & Associates的演讲酬金;
更新日期:2024-10-21
Journal of Hepatology ( IF 26.8 ) Pub Date : 2024-10-21 , DOI: 10.1016/j.jhep.2024.10.021 Vlad Taru, Thomas Reiberger
Section snippets
Author contributions:
VT and TR both drafted and reviewed the reply letter for intellectual content.Financial support:
none.Declaration of Competing Interest:
VT is funded by the Christian-Doppler Research Association and Boehringer Ingelheim RCV GmbH & Co KG (CD10271603); Romanian Ministry of Research, Innovation and Digitalization (PNRR/2022/C9/MCID/I8).TR received grant support from Abbvie, Boehringer Ingelheim, Gilead, Intercept/Advanz Pharma, MSD, Myr Pharmaceuticals, Philips Healthcare, Pliant, Siemens and W. L. Gore & Associates; speaking honoraria from Abbvie, Echosens, Gilead, Intercept/Advanz Pharma, Roche, MSD, W. L. Gore & Associates;中文翻译:
回复: “肝衰竭中的细胞焦亡:扭曲的纵火者”
部分片段
作者贡献:
VT 和 TR 都起草并审查了知识内容的回复信。
资金支持:
没有。
利益争夺声明:
VT由基督教-多普勒研究协会和勃林格殷格翰RCV GmbH & Co KG(CD10271603)资助;罗马尼亚研究、创新和数字化部(PNRR/2022/C9/MCID/I8).TR获得了Abbvie、Boehringer Ingelheim、Gilead、Intercept/Advanz Pharma、MSD、Myr Pharmaceuticals、Philips Healthcare、Pliant、Siemens和W. L. Gore & Associates的资助;来自Abbvie, Echosens, Gilead, Intercept/Advanz Pharma, Roche, MSD, W. L. Gore & Associates的演讲酬金;